About me
Proud to be leading Integra Therapeutics, a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies to cure genetic and oncological diseases with high unmet medical need.
I have a strong scientific background in clinical genetics, molecular oncology, and synthetic biology, and experience in business management in biotechnology.
I did my PhD at the Institute of Biomedicine of Seville and post-doc at the National University of Singapore and University of Miami Miller School of Medicine. In 2018, I joined the Translational Synthetic Biology Lab at Pompeu Fabra University, led by Dr Marc Güell, as Senior Researcher. In recent years, I have focused on successful technology transfer from academia to society through the entrepreneurial project Integra Therapeutics.
I'm committed to helping develop female talent and encouraging coming generations to go into STEM fields. In 2022, I received Women and Leadership Award promoted by Deusto Business School, Cinco Días and Banco Santander.
For further information about Integra, please visit: integra-tx.com
